There’s been an explosion of interest in psychedelics over the last 10 years, and phrases like “psychedelic-assisted therapy” have gone from the relative fringes of the mental health conversation to bursting into the mainstream. Alongside a great deal of hype is a growing body of research revealing the potential of substances like psilocybin and MDMA as novel treatments for depression, addiction, and PTSD. On today’s episode of Being Well, I am joined by Dr. Albert Garcia-Romeu from the Johns Hopkins Center for Psychedelic and Consciousness Research. We explore the history and current state of psychedelic research, their subjective effects, the necessity of the “trip,” how psychedelics work in the brain, why researchers are so interested in these substances, and what a psychedelic-assisted therapy session looks like. About Our Guest: Dr. Garcia-Romeu is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction.